Tech&Science

French Biotech Player FÉLICIA BEAUTÉ Debuts "Cellular-Level" Anti-Ageing Protocol at SupplySide Global

Feb 10, 2026

French premium health brand FÉLICIA BEAUTÉ has formally entered the global market, unveiling its flagship "Black Gold Bottle™" at the SupplySide Global trade show in Las Vegas. The launch marks a strategic shift in the anti-ageing sector, moving from topical treatments to systemic cellular intervention.

The Shift to Micro-Level Maintenance As consumer demand evolves from "surface improvement" to "root cause reversal," the health industry is undergoing a significant transition. While early anti-ageing solutions focused on epidermal hydration or aesthetic shaping, these methods often failed to address the fundamental biological drivers of decline. FÉLICIA BEAUTÉ’s entry signals a move towards "precision cellular nutrition," a growing category addressing ageing at its microscopic source.

 

The "3D" Systemic Approach Aligned with international academic trends that identify mitochondrial dysfunction and the loss of autophagy as key ageing markers, the brand has introduced a "3-Dimensional Anti-Ageing System". Unlike traditional single-nutrient supplements, this protocol targets the biological lifecycle on three tiers:

 

Cellular: Promoting autophagy (clearing metabolic waste) and recharging mitochondria.

Organ: Supporting tissue repair and function.

Systemic: Improving overall vitality and physiological state.

Key Active Ingredients The proprietary formula presented at the expo integrates three high-potency components:

 

L-Ergothioneine: Utilized as a primary antioxidant to target mitochondrial free radicals.

French Black Truffle: Sourced for its amino acid profile to activate the SIRT protein family (longevity genes) and support cell renewal.

Gerolytix™ Complex: A patented blend designed to clear senescent "zombie" cells and fuel regeneration.

 

Regional Ties and Manufacturing Standards FÉLICIA BEAUTÉ is incubated by Laboratoire CEVRAI, a French nutritional leader established in 1991 by agronomist Serge Thivin. Of particular relevance to the Australasian market, the brand operates a production matrix spanning both Europe and Oceania, integrating global resources with over 30 core formulation technologies.

 

This dual-region manufacturing capability allows the brand to maintain strict quality controls while servicing the growing demand in the Asia-Pacific region for scientifically validated health products.